GPT and osteosarcoma: Patients with lower LAP2α expression in ALT-positive osteosarcoma exhibit a poorer prognosis and lower survival rates, prompting the consideration of whether attenuated heterochromatinization caused by LAP2α depletion can impede the growth of ALT tumors.